Nintendo developing cloud-based sleep-monitoring device amid market growth

Nintendo's sleep-monitoring system will track and analyze a user's sleep using cloud technology.--Courtesy of Nintendo

As med tech companies roll out innovative products to treat sleep disorders, electronics outfit Nintendo is looking to cash in on the trend with a new sleep-monitoring device that runs on its health-focused platform.

The Japanese company is developing a sensor tool that uses radio waves to track an individual's vital signs as they sleep, and connects with smart devices and video game devices through cloud technology to analyze a user's health information, Polygon reports. The product is non-wearable and non-contact, and operates on its own without much setup.

Nintendo will partner with U.S.-based medical device manufacturer ResMed to distribute its sleep-monitor product, and expects to launch the device sometime in 2016, according to the Polygon story.

Meanwhile, devicemakers are eyeing a $3.5 billion sleep disorder market as potential source of growth. Medtronic ($MDT) spinoff Inspire Medical Systems is developing the first and only implantable neurostimulation device to treat sleep apnea, providing an alternative to traditional continuous positive airway pressure (CPAP) therapy. In May, the Minneapolis-based company raked in $40 million in a Series E round to launch its Inspire implant in the U.S.

Inspire Medical Systems is not alone in its quest to create next-generation sleep devices. Israel's Itamar Medical recently celebrated positive third quarter results buoyed by new sales deals for its home sleep monitoring system. The company's WatchPAT and EndoPAT diagnostic devices use a fingertip sensor to track the health of nerves and blood vessels, providing a noninvasive "window" to the cardiovascular system and autonomic nervous system. Itamar in the first half of 2014 brought in $16.3 million from Israeli investors for its sleep-monitoring products, and inked deals with big names like Medtronic, a Japanese unit of Philips ($PHG), and Nihon Kohden, one of Japan's largest medical device manufacturers.

- read the Polygon article

Special Report: FierceMedicalDevices' 2014 Fierce 15 - Inspire Medical Systems - 2014 Fierce 15

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.